Trial
NCT03831191
A Study of LY3375880 in Adults With Moderate-to-Severe Atopic Dermatitis
Phase IITERMINATEDEFFICACY/FUTILITYConfidence: MEDIUM
Sponsor
Eli Lilly and Company
Collaborators
—
Condition
Atopic Dermatitis
Intervention
LY3375880
Why stopped
The study was terminated for lack of efficacy after an interim analysis was performed
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2021-04-20